1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.29%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
2.22%
Positive gross profit growth while FSLR is negative. John Neff would see a clear operational edge over the competitor.
12.60%
EBIT growth above 1.5x FSLR's 5.98%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
9.04%
Operating income growth above 1.5x FSLR's 5.98%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
10.29%
Positive net income growth while FSLR is negative. John Neff might see a big relative performance advantage.
20.24%
Positive EPS growth while FSLR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.24%
Positive diluted EPS growth while FSLR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
14.39%
Share count expansion well above FSLR's 0.51%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
14.39%
Diluted share count expanding well above FSLR's 0.51%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-202.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-292.59%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
39.48%
10Y revenue/share CAGR under 50% of FSLR's 7241.28%. Michael Burry would suspect a lasting competitive disadvantage.
128.96%
5Y revenue/share CAGR under 50% of FSLR's 520.91%. Michael Burry would suspect a significant competitive gap or product weakness.
73.16%
3Y revenue/share CAGR above 1.5x FSLR's 12.23%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
75.96%
OCF/share CAGR of 75.96% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-822.78%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-92.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
67.76%
Positive 10Y CAGR while FSLR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-4064.44%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-466.76%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
29.34%
Below 50% of FSLR's 602.15%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-16.57%
Negative 3Y equity/share growth while FSLR is at 77.65%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.84%
AR growth well above FSLR's 2.79%. Michael Burry fears inflated revenue or higher default risk in the near future.
15.80%
Inventory growth well above FSLR's 22.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.87%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.65%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-28.87%
We’re deleveraging while FSLR stands at 30.24%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
39.51%
We increase R&D while FSLR cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.21%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.